BioSpace News Archive

Biorasi , a leading global full-service contract research organization (CRO), is proud to announce the appointment of Robert S. Negrin, MD to the position of Scientific Advisory Board (SAB) member.

Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is thrilled to announce the release of its latest edition full-line product catalog, available in both print and digital formats.

Neuroelectrics, a pioneer in brain stimulation technologies and therapies, has raised $17.5M in a Series A financing led by Morningside Ventures.

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following three virtual investor conferences in May:.

ivWatch’s Family of IV Site Monitoring Products Now Available to More Than 4,000 Premier Hospitals with New Three-Year Agreement

FEMSelect, the developer of EnPlace™, a minimally invasive, meshless approach to pelvic floor ligament fixation, and LiNA Medical USA today announced a strategic sales partnership to reach pelvic floor surgeons across the United States with the EnPlace™ system.

Immunovia AB announced that the following members of the Board of Directors have purchased shares in the company

Origami Therapeutics http://origamitherapeutics.com , a discovery-stage company taking a precision medicine approach to discover disease-modifying treatments for neurodegeneration, announced today it has been selected as one of 13 life science “Cool Companies for 2021" by Connect.

ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Systems, announced the closing of a $24 million investment from Morgan Stanley Expansion Capital.

U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for direct application system and method for the delivery of bioactive compositions and formulations .